DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 153 filers reported holding DIPLOMAT PHARMACY INC in Q1 2019. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $765,000 | -48.7% | 56,827 | -26.1% | 0.02% | -39.3% |
| Q3 2018 | $1,492,000 | -20.2% | 76,874 | +5.2% | 0.03% | -39.1% |
| Q2 2018 | $1,869,000 | +16.9% | 73,074 | -8.0% | 0.05% | +21.1% |
| Q1 2018 | $1,599,000 | +33.7% | 79,393 | +33.1% | 0.04% | +22.6% |
| Q4 2017 | $1,196,000 | -9.2% | 59,661 | -6.2% | 0.03% | -3.1% |
| Q3 2017 | $1,317,000 | +41.0% | 63,589 | +0.8% | 0.03% | +33.3% |
| Q2 2017 | $934,000 | +926.4% | 63,072 | +1014.1% | 0.02% | +1100.0% |
| Q1 2017 | $91,000 | +31.9% | 5,661 | +3.2% | 0.00% | 0.0% |
| Q4 2016 | $69,000 | -54.9% | 5,486 | 0.0% | 0.00% | -71.4% |
| Q3 2016 | $153,000 | -5.0% | 5,486 | +19.2% | 0.01% | -12.5% |
| Q2 2016 | $161,000 | – | 4,602 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |